Testing Cysteamine for cystinosis bone health
Treatments studied
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This study looks at how cysteamine affects the bone health of people with nephropathic cystinosis, a rare genetic condition. It includes children and adults who are already taking cysteamine by mouth and will follow the study plan closely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your child) have confirmed nephropathic cystinosis.
- You are currently taking cysteamine by mouth (oral cysteamine).
- You are older than 2 years.
- You (and/or your parent/guardian) agree to take part by giving written non-opposition/permission.
- You are able and willing to follow all study visits and instructions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called TTI-0102 for cystinosis. It aims to see if it can help manage cystine levels in the body, which may reduce kidney and other organ damage.
This trial tests a new gene therapy called DFT383 for children aged 2 to 5 with nephropathic cystinosis. It aims to see if the treatment is safe and can help improve kidney function.
This study looks at how cystinosis affects the energy centers (mitochondria) in your cells. It may help doctors understand how cysteamine treatment works in patients with kidney cystinosis.
This study looks at whether having a change in the CYP24A1 gene raises the risk of kidney stones. It involves collecting urine for 24 hours and a day at the hospital. The results may help understand why some people get kidney stones and guide future care.
This trial looks at the use of cysteamine to treat cystinosis, a rare inherited condition. It may help lower harmful cystine buildup in the body and improve outcomes, especially early in life.
This study is a follow-up registry for people with cystinosis to track their health over time. It helps doctors learn more about the condition and how it affects daily life, without giving any new treatments.
Hear when a new Nephropathic Cystinosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.